Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,701,747
-
Share change
-
-2,066,879
-
Total reported value
-
$27,335,905
-
Put/Call ratio
-
0.83%
-
Price per share
-
$1.26
-
Number of holders
-
76
-
Value change
-
-$2,979,361
-
Number of buys
-
22
-
Number of sells
-
35
Institutional Holders of HOMOLOGY MEDICINES INC - COM (FIXX) as of Q4 2022
As of 31 Dec 2022,
HOMOLOGY MEDICINES INC - COM (FIXX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,701,747 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, 5AM Venture Management, LLC, VANGUARD GROUP INC, Bellevue Group AG, BlackRock Inc., CITADEL ADVISORS LLC, Erste Asset Management GmbH, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and Vivo Capital, LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.